118 research outputs found
Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ
Serial monitoring of plasma DNA mutations in estrogen receptor positive metastatic breast cancer (ER + MBC) holds promise as an early predictor of therapeutic response. Here, we developed dPCR-SEQ, a customized assay that utilizes digital PCR-based target enrichment followed by next-generation sequencing to analyze plasma DNA mutations in ESR1, PIK3CA, and TP53. We validated dPCR-SEQ in a prospective cohort of 58 patients with ER + MBC and demonstrate excellent concordance with hotspot ESR1 mutation abundance measured by conventional digital PCR. The dPCR-SEQ assay revealed ESR1, PIK3CA, and TP53 plasma ctDNA mutations in 55%, 32%, and 32% of the study patients, respectively. We also observed dynamic changes in ESR1, PIK3CA, and TP53 ctDNA mutant allele fraction (MAF) that were frequently discordant between the different genes. Thus, monitoring plasma DNA mutation dynamics using a dPCR-SEQ assay is feasible, accurate, and may be investigated as a biomarker of therapeutic response in ER + MBC
Rapid clearance profile of plasma circulating tumor HPV type 16 DNA during chemoradiotherapy correlates with disease control in HPV-associated oropharyngeal cancer
Purpose: To identify a profile of circulating tumor human papilloma virus (HPV) DNA (ctHPVDNA) clearance kinetics that is associated with disease control after chemoradiotherapy (CRT) for HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). Experimental Design: A multi-institutional prospective biomarker trial was conducted in 103 patients with (i) p16- positive OPSCC, (ii) M0 disease, and (iii) receipt of definitive CRT. Blood specimens were collected at baseline, weekly during CRT, and at follow-up visits. Optimized multianalyte digital PCR assays were used to quantify ctHPVDNA (types 16/18/31/33/35) in plasma. A control cohort of 55 healthy volunteers and 60 patients with non-HPV-associated malignancy was also analyzed. Results: Baseline plasma ctHPVDNA had high specificity (97%) and high sensitivity (89%) for detecting newly diagnosed HPV-associated OPSCC. Pretreatment ctHPV16DNA copy number correlated with disease burden, tumor HPV copy number, and HPV integration status. We define a ctHPV16DNA favorable clearance profile as having high baseline copy number (>200 copies/mL) and >95% clearance of ctHPV16DNA by day 28 of CRT. Nineteen of 67 evaluable patients had a ctHPV16DNA favorable clearance profile, and none had persistent or recurrent regional disease after CRT. In contrast, patients with adverse clinical risk factors (T4 or >10 pack years) and an unfavorable ctHPV16DNA clearance profile had a 35% actuarial rate of persistent or recurrent regional disease after CRT (P = 0.0049). Conclusions: A rapid clearance profile of ctHPVDNA may predict likelihood of disease control in patients with HPVassociated OPSCC patients treated with definitive CRT and may be useful in selecting patients for deintensified therapy
Search for the Rare Decays J/Psi --> Ds- e+ nu_e, J/Psi --> D- e+ nu_e, and J/Psi --> D0bar e+ e-
We report on a search for the decays J/Psi --> Ds- e+ nu_e + c.c., J/Psi -->
D- e+ nu_e + c.c., and J/Psi --> D0bar e+ e- + c.c. in a sample of 5.8 * 10^7
J/Psi events collected with the BESII detector at the BEPC. No excess of signal
above background is observed, and 90% confidence level upper limits on the
branching fractions are set: B(J/Psi --> Ds- e+ nu_e + c.c.)<4.8*10^-5, B(J/Psi
--> D- e+ nu_e + c.c.) D0bar e+ e- + c.c.)<1.1*10^-5Comment: 10 pages, 4 figure
Study of J/psi decays to Lambda Lambdabar and Sigma0 Sigma0bar
The branching ratios and Angular distributions for J/psi decays to Lambda
Lambdabar and Sigma0 Sigma0bar are measured using BESII 58 million J/psi.Comment: 11 pages, 5 figure
Measurement of \chi_cJ--> K+K-K+K-
Using 14M psi(2S) events taken with the BES-II detector, chi_cJ-->K+K-K+K-
decays are studied. For the four-kaon final state, the branching fractions are
B(chi_c0,1,2 -->K+K-K+K-)=(3.48\pm 0.23\pm 0.47)\times 10^{-3}, (0.70\pm
0.13\pm 0.10)\times 10^{-3}, and (2.17\pm 0.20\pm 0.31)\times 10^{-3}. For the
\phi K+K- final state, the branching fractions, which are measured for the
first time, are B(chi_c0,1,2-->\phi K+K-)=(1.03\pm 0.22\pm 0.15)\times 10^{-3},
(0.46\pm 0.16\pm 0.06)\times 10^{-3}, and (1.67\pm 0.26\pm 0.24)\times 10^{-4}.
For the \phi\phi final state, B(chi_{c0,2}-->\phi\phi)=(0.94\pm 0.21\pm
0.13)\times 10^{-3} and (1.70\pm 0.30\pm 0.25)\times 10^{-3}.Comment: 7 pages, 7 figure
Partial wave analyses of J/psi to gamma pi^+ pi^- and gamma pi^0 pi^0
Results are presented on J/psi radiative decays to pi^+pi^- and pi^0pi^0
based on a sample of 58M J/psi events taken with the BESII detector. Partial
wave analyses are carried out using the relativistic covariant tensor amplitude
method in the 1.0 to 2.3 GeV/c^2 pipi mass range. There are conspicuous peaks
due to the f_2(1270) and two 0^++ states in the 1.45 and 1.75 GeV/c^2 mass
regions. The first 0^++ state has a mass of 1466\pm 6\pm 20 MeV/c^2, a width of
108^{+14}_{-11}\pm 25 MeV/c^2, and a branching fraction B(J/psi \to \gamma
f_0(1500) \to\gamma \pi^+\pi^-) = (0.67\pm0.02\pm0.30) \times 10^{-4}. Spin 0
is strongly preferred over spin 2. The second 0^++ state peaks at
1765^{+4}_{-3}\pm 13 MeV/c^2 with a width of 145\pm8\pm69 MeV/c^2. If this 0^++
is interpreted as coming from f_0(1710), the ratio of its branching fractions
to pipi and K\bar K is 0.41^{+0.11}_{-0.17}.Comment: 9 pages, 6 figure
Evidence for kappa Meson Production in J/psi -> bar{K}^*(892)^0K^+pi^- Process
Based on 58 million BESII J/psi events, the bar{K}^*(892)^0K^+pi^- channel in
K^+K^-pi^+pi^- is studied. A clear low mass enhancement in the invariant mass
spectrum of K^+pi^- is observed. The low mass enhancement does not come from
background of other J/psi decay channels, nor from phase space. Two independent
partial wave analyses have been performed. Both analyses favor that the low
mass enhancement is the kappa, an isospinor scalar resonant state. The average
mass and width of the kappa in the two analyses are 878 +- 23^{+64}_{-55}
MeV/c^2 and 499 +- 52^{+55}_{-87} MeV/c^2, respectively, corresponding to a
pole at (841 +- 30^{+81}_{-73}) - i(309 +- 45^{+48}_{-72}) MeV/c^2.Comment: 17 pages, 5 figure
Measurements of the cross sections for at 3.650, 3.6648, 3.773 GeV and the branching fraction for
Using the BES-II detector at the BEPC Collider, we measured the lowest order
cross sections and the values () for inclusive hadronic event
production at the center-of-mass energies of 3.650 GeV, 3.6648 GeV and 3.773
GeV. The results lead to which is the
average of these measured at 3.650 GeV and 3.6648 GeV, and at GeV. We determined the lowest order cross
section for production to be at 3.773 GeV, the branching fractions for
decays to be , and , which result in the total non-
branching fraction of decay to be .Comment: 11 pages, 5 figure
Precison Measurements of the Mass, the Widths of Resonance and the Cross Section at GeV
By analyzing the values measured at 68 energy points in the energy region
between 3.650 and 3.872 GeV reported in our previous paper, we have precisely
measured the mass, the total width, the leptonic width and the leptonic decay
branching fraction of the to be MeV, MeV,
eV and , respectively, which result in
the observed cross section nb at MeV. We have also measured for the continuum light hadron production in the
region from 3.650 to 3.872 GeV.Comment: 5 pages, 2 figure
- …